IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript

The aim of the International Institute of Anticancer Research (IIAR) is to provide an independent platform for international cooperation in the fight against cancer. The IIAR will advance, protect and support throughout the world the ideals of freedom, peace, health, scientific knowledge, equality, welfare and mutual respect among communities in science and life.This site provides information on the aims and activities of the IIAR, including current cancer research projects and invitations for cooperation.
The IIAR is supported by the three international peer-reviewed journals ANTICANCER RESEARCH, IN VIVO and CANCER GENOMICS & PROTEOMICS which are available online through the Stanford University HighWire Press
The IIAR is a member of the UICC


ANTICANCER RESEARCH USA, Inc.
Editorial office: 111 Bay Avenue, Highlands, NJ 07732, USA.
Mailing address: Anticancer Research USA, Inc., P.O.B. 280, Belmar, NJ 07719, USA.
e-mail: journals@iiar-anticancer.org

In Vivo

Anticancer Research

Anticancer Research is an international print and online monthly journal designed to rapidly publish peer-reviewed original papers and reviews on experimental and clinical cancer research.
Established: 1981

Anticancer Research is online from January 2009 issue with Stanford University HighWire Press with access to Full-text articles. From all previous volumes since January 1st, 2004, articles are available as PDF. Articles published before 2004 (Volumes 1/1981 - 23/2003) are available through the Editorial Office.

Current issue contents

In Vivo

In Vivo

In Vivo is an international journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of human physiology, pathology and disease management.
Established: 1987

From January 2017 In Vivo is published online - only with open access through Stanford University HighWire Press. Free online access of Full-text or PDF (from January 2009), or PDF-only (from January 2004 to December 2008) articles will be available through Stanford University HighWire Press. Articles published before 2004 (Volumes 1/1987 - 17/2003) are available through the Editorial Office.

Current issue contents

Cancer Genomics & Proteomics

Cancer Genomics & Proteomics

Cancer Genomics & Proteomics (CGP) is an international journal designed to rapidly publish high quality articles and reviews on the application of genomic and proteomic technology to experimental and clinical cancer research.
Established: 2004

Cancer Genomics & Proteomics (CGP) is published online-only with open access through Stanford University HighWire Press.

Current issue contents

CALL FOR PAPERS
IN VIVO Special Issue On SARS-Cov-2 and Covid-19 Disease

TOPICS: Reviews, experimental and clinical articles on all aspects of SARS-Cov-2 and Covid-19 disease.

Deadline for article submission: 18 May 2020
Publication Policy: Submitted articles should not exceed 20 typewritten pages plus figures and tables.

  • All submitted manuscripts will be rapidly peer-reviewed within 3-5 days, and Authors will be immediately noticed if a revision is requested. Revised manuscripts should reach our office within 24-48 hours. Prompt arrangements focus on the rapid publication of this issue online OPEN ACCESS in the Highwire-IN VIVO site on June 2, 2020.
  • All accepted papers will be subject to a publication fee of US$ 250.00. Color figures will be published free of charge.
  • Manuscripts should follow our Instructions to Authors and should be submitted electronically (www.iiar-submissions.com).

Information: Dr. George J. Delinasios, e-mail: journals@iiar-anticancer.org

Now you can access the entire contents of the IIAR journals published from 2013 till today
with ease on your Android©  phone or tablet with our newly designed app, freely available on Google Play Store

Special Issue of Anticancer Research
on “New Anticancer Agents” 2020

TOPICS:   A. Experimental studies on “New Anticancer Agents”
1. Synthesis and evaluation in vitro and in vivo, 2. Mechanism of action,
3. Reversal of resistance to anticancer agents, 4. Oncolytic viruses

                 B. Clinical studies on “New Anticancer Agents”
1. Pharmacology, 2. Clinical trials, 3. Combination chemotherapy, 4. Immunotherapeutic agents,
5. New methodologies in drug delivery, 6. Vaccines

Deadline for article submission: June 25, 2020.
Publication: September 2020.
Information: Dr. George J. Delinasios, e-mail: journals@iiar-anticancer.org

All content of ANTICANCER RESEARCH published between 2004 and 2015 is online available free to all.
IN VIVO (from January 2017) and CANCER GENOMICS & PROTEOMICS (from January 2013) are published online-only with open access.

Upon permission of the presenters, the lectures of the 9th Conference of Anticancer Research, 6 – 10 October 2014, Sithonia, Greece,
are available online with open access here

 

Should you come across any errors in this website, please inform: admin@iiar-anticancer.org

IMPORTANT NOTE: You may submit your article only through our online submission system

Submit your manuscript